TAKE THIS POLL |
|
|
- More Women Choosing Double Mastectomy Surgery 21 Aug 2008 17:57 GMT
... When it comes to breast cancer, the figures don’t look good at all. ... as 85 percent and the risk of ovarian cancer by as much as 40 percent. ...
- Vanessa Muradian: Taking time for a test of love 21 Aug 2008 17:55 GMT
... a cup of tea I would never forget. Mum had been diagnosed with fourth-stage ovarian cancer. There are only four stages of cancer. "Fourth stage" usually means the victim will ...
- Back-to-school haircut an act of love 21 Aug 2008 17:38 GMT
... cousin, Noelle Estrada-Boss. Estrada-Boss died in 2005 at the age of 25 after battling ovarian cancer. "When my niece passed away, we decided we'd grow it out," said Richard Estrada, ...
- Any Lab Test Now opens second St. Louis location 21 Aug 2008 17:11 GMT
... retail setting. The lab offers tests of cholesterol, glucose, liver function, thyroid, STDs, prostate cancer, ovarian cancer, pregnancy, paternity and drug screening. The lab also serves the employer community with ...
- Treatment Advance for Drug-Resistant Diseases 21 Aug 2008 17:11 GMT
... ranging from superbug infections to tuberculosis and cancer. US researchers believe they have found a ... drug resistance that is frequently seen in ovarian cancer patients given the drug Taxol – ...
- Zoledronate Prevents Bone Loss During Endocrine Treatment for Breast Cancer 21 Aug 2008 16:09 GMT
... Bone Loss During Endocrine Treatment for Breast Cancer NEW YORK AUG 20, 2008 (Reuters Health) ... trial to assess the efficacy of goserelin-induced ovarian suppression plus or anastrozole, with or without ...
- Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceut 21 Aug 2008 15:30 GMT
... distinct unmet needs in the treatment of cancer, including three candidates in various stages of ... tumors, including prostate, breast, non-small cell lung, ovarian, and bladder cancers. It has potential applicability ...
- How to avoid breast cancer 21 Aug 2008 15:20 GMT
... This is Breast Cancer Awareness month, and thousands of women are ... of women will have developed breast cancer, ovarian cancer and endometrial cancer (of the lining ...
- LifeVantage Corporation, Maker of Protandim(R), Joins Forces with Cornerstone R&D, Inc. to Dramatically Cut Manufacturing Costs 21 Aug 2008 14:59 GMT
... MAGNETIC NANOPARTICLES COMBAT CANCER - Interview with John McDonald, Ph.D., Professor ... Tech and Chief Research Scientist at the Ovarian Cancer Institute ... ...
- Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence tr 21 Aug 2008 14:57 GMT
... distinct unmet needs in the treatment of cancer, including three candidates in various stages of ... tumors, including prostate, breast, non-small cell lung, ovarian, and bladder cancers. It has potential applicability ...
- Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today 21 Aug 2008 14:54 GMT
... distinct unmet needs in the treatment of cancer, including three candidates in various stages of ... tumors, including prostate, breast, non-small cell lung, ovarian, and bladder cancers. It has potential applicability ...
- EMRISE Corporation Completes Acquisition of Advanced Control Components Inc. 21 Aug 2008 14:28 GMT
... MAGNETIC NANOPARTICLES COMBAT CANCER - Interview with John McDonald, Ph.D., Professor ... Tech and Chief Research Scientist at the Ovarian Cancer Institute ... ...
- 4C Controls Announces Appointment of Major General Khalid Abdulla Mabarak Al Buainain, Commander & Chief of UAE Air Force and Air Defense (Ret.), as Vice President for Middle East Military and Defense Security 21 Aug 2008 14:00 GMT
... MAGNETIC NANOPARTICLES COMBAT CANCER - Interview with John McDonald, Ph.D., Professor ... Tech and Chief Research Scientist at the Ovarian Cancer Institute ... ...
- Asteres Inc. Selects Pitney Bowes as National Multi-Vendor Services Provider for Automated Prescription Pick-up Kiosks 21 Aug 2008 14:00 GMT
... MAGNETIC NANOPARTICLES COMBAT CANCER - Interview with John McDonald, Ph.D., Professor ... Tech and Chief Research Scientist at the Ovarian Cancer Institute ... ...
- Hospitals Spending More Money to Make Patients Comfortable 21 Aug 2008 13:59 GMT
... of helplessness, and perhaps influence a patient's outcome for the better. To treat the ovarian cancer she has been fighting since 2002, Kathleen Donoghue must spend an hour at a ...
- Resurgent Health and Medical's handwashing systems removed 99.997% of E-Coli in Laboratory Studies 21 Aug 2008 13:36 GMT
... MAGNETIC NANOPARTICLES COMBAT CANCER - Interview with John McDonald, Ph.D., Professor ... Tech and Chief Research Scientist at the Ovarian Cancer Institute ... ...
- Family stages walk to combat ovarian cancer 21 Aug 2008 13:34 GMT
... am gone," said the 60-year-old Farmington Hills resident, before she lost her battle with ovarian cancer. "Take care of each other." But it's still a daily struggle for her loved ...
- Notice of Q2 2008 Results Conference Call 21 Aug 2008 13:29 GMT
... MAGNETIC NANOPARTICLES COMBAT CANCER - Interview with John McDonald, Ph.D., Professor ... Tech and Chief Research Scientist at the Ovarian Cancer Institute ... ...
- Status Equity Research Initiates Coverage of OncoVista Innovative Therapies, Inc. (OVIT.OB) -- Long Term Target Price $16.00 21 Aug 2008 13:29 GMT
... MAGNETIC NANOPARTICLES COMBAT CANCER - Interview with John McDonald, Ph.D., Professor ... Tech and Chief Research Scientist at the Ovarian Cancer Institute ... ...
- Revolutions Medical Finishes Filing Its International Patent Protection for the Rev Vac Safety Syringe 21 Aug 2008 13:06 GMT
... MAGNETIC NANOPARTICLES COMBAT CANCER - Interview with John McDonald, Ph.D., Professor ... Tech and Chief Research Scientist at the Ovarian Cancer Institute ... ...
- LUMEDX Introduces Advanced Multi-Modality, Multi-Vendor, Web-Enabled ECG Management Solution 21 Aug 2008 13:00 GMT
... MAGNETIC NANOPARTICLES COMBAT CANCER - Interview with John McDonald, Ph.D., Professor ... Tech and Chief Research Scientist at the Ovarian Cancer Institute ... ...
- Acorda Therapeutics' Preclinical Pipeline Named One of the 10 Most Promising Neuroscience Projects Available for Partnering by Windhover 21 Aug 2008 12:59 GMT
... MAGNETIC NANOPARTICLES COMBAT CANCER - Interview with John McDonald, Ph.D., Professor ... Tech and Chief Research Scientist at the Ovarian Cancer Institute ... ...
- HLS Promotes From Within and Hires Fresh Talent 21 Aug 2008 12:54 GMT
... MAGNETIC NANOPARTICLES COMBAT CANCER - Interview with John McDonald, Ph.D., Professor ... Tech and Chief Research Scientist at the Ovarian Cancer Institute ... ...
- Universal Detection Technology Receives Purchase Order From NovaMed for Its Anti-Microbial Washing Machine Additive 21 Aug 2008 12:54 GMT
... MAGNETIC NANOPARTICLES COMBAT CANCER - Interview with John McDonald, Ph.D., Professor ... Tech and Chief Research Scientist at the Ovarian Cancer Institute ... ...
- Hospitals Trying to Make Comfort a Priority for Patients 21 Aug 2008 12:54 GMT
... of helplessness, and perhaps influence a patient's outcome for the better. To treat the ovarian cancer she has been fighting since 2002, Kathleen Donoghue must spend an hour at a ...
1 - 25 of 770 next >
News by PR Newswire
|
